Navigation Links
The Effects Of Estrogen Therapy

Taking estrogen alone will not prevent chronic diseases in postmenopausal women who have had a hysterectomy. However it is found to increase // the risk of stroke and decrease the risk of hip factures, according to the latest research.

For the study investigators examined whether conjugated equine estrogen alone or in combination with progestin would reduce coronary heart disease events in mostly healthy women. Postmenopausal American women use CEE more frequently than any other hormone therapy.The estrogen-alone trial was halted because researchers found it had no significant effect on reducing the risk of coronary heart disease but it did cause a significant increase in stroke risk. The estrogen-plus-progestin portion of the trial was also halted because researchers said the health risks exceeded the benefits.

Although estrogen alone did increase the risk of stroke and deep-vein thrombosis, it did not significantly affect the risk of pulmonary embolism, colorectal cancer or breast cancer. Also, researchers say women on estrogen-alone suffered fewer hip fractures than women on a placebo.

Thus researchers say women can continue to take estrogen-alone for postmenopausal symptoms, but they should only take the smallest effective dose for the shortest possible time. Since estrogen-alone seems to offer no overall health benefits, the researchers say it should not be used for these purposes.
'"/>




Page: 1

Related medicine news :

1. Acupuncture May Help Chemotherapy Side Effects
2. Chemotherapy Pill Has Fewer Side Effects Than IV
3. Therapy Boosts Chemotherapy Effects
4. Smoking and its Effects
5. Reducing The After Effects of Tonsillectomy
6. The Side Effects Of Estrogen Therapy
7. The Harmful Effects Of Cigarette Smoke
8. Lung Therapy Found To Have Long-Term Side Effects
9. The After Effects Of Pneumonia
10. The Effects Of Dental X-Rays During Pregnancy Questioned
11. The Effects Of Coffee
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... December 05, 2016 , ... A ... Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with little ... , Over the last 60 years, studies have shown that single electrode misplacement ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® ... area” Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony ... Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ...
(Date:12/4/2016)... Washington DC (PRWEB) , ... December 04, 2016 , ... ... Environmental, one of the most certified and experienced Indoor Air Quality Companies in VA, ... Assessment and Remediation Regulations. , The new mold law in the district ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 /PRNewswire/ ... ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic ... safety and tolerability profile of ropeginterferon alfa-2b versus HU ... the ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing ... to present this data to the FDA as it seeks ...
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: